Use of Omalizumab in children in real clinical practice.
S. Zaytseva (Moscow, Russian Federation), O. Zaytseva (Moscow, Russian Federation), E. Lokshina (Moscow, Russian Federation), A. Tomilova (Moscow, Russian Federation), O. Voronina (Moscow, Russian Federation), O. Murtazaeva (Moscow, Russian Federation), . Mukhortykh (Moscow, Russian Federation), I. Tsymbal (Moscow, Russian Federation)
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Zaytseva (Moscow, Russian Federation), O. Zaytseva (Moscow, Russian Federation), E. Lokshina (Moscow, Russian Federation), A. Tomilova (Moscow, Russian Federation), O. Voronina (Moscow, Russian Federation), O. Murtazaeva (Moscow, Russian Federation), . Mukhortykh (Moscow, Russian Federation), I. Tsymbal (Moscow, Russian Federation). Use of Omalizumab in children in real clinical practice.. 3918
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: